Results 71 to 80 of about 16,837 (241)

Clinical Diagnostic Accuracy of Onychomycosis: A Multispecialty Comparison Study

open access: yesDermatology Research and Practice, 2018
Although onychomycosis can be diagnosed clinically, many guidelines still recommend pathologic confirmation of the diagnosis prior to initiation of systemic treatment. We retrospectively reviewed results from 541 toenail clippings (160 by dermatologists,
David G. Li   +5 more
doaj   +1 more source

بررسی فراوانی اونيکومايکوزيس ناشی از قارچ های مخمری در ناخن های ديستروفيک بيماران مراجعه کننده به بيمارستان رازی 90-1389 [PDF]

open access: yes, 2012
زمينه و هدف : مخمرها يکی از شايع‌ترين عوامل ايجادکنندۀ اونيکومايکوزيس می‌باشند. در کشورهايی مثل ايران، عربستان، ايتاليا و اسپانيا مخمرها بيشترين فراوانی گزارش شده را دارند.
احمدی, فرزانه   +6 more
core  

Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects

open access: yesMemorias do Instituto Oswaldo Cruz, 2005
Knowledge of epidemiological and mycological characteristics of onychomycosis has been noted by many authors as being an important tool for control of these fungal infections.
RSN Brilhante   +7 more
doaj   +1 more source

Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample

open access: yesDermatology Practical & Conceptual
Introduction: Onychomycosis, a fungal nail infection, is associated with significant morbidity and negative impact on quality of life. Therefore, understanding associated risk factors may inform onychomycosis screening guidelines.
Vrusha Shah, Amar Desai, Shari Lipner
doaj   +1 more source

Propolis for the Treatment of Onychomycosis.

open access: yesIndian journal of dermatology, 2018
Onychomycosis is a fungal nail infection, considered as a public health problem because it is contagious and it interferes with the quality of life. It has long and difficult treatment, with many side effects and high cost. Propolis extract (PE) is a potential alternative to conventional antifungal agents because it has low cost, accessibility, and low
Érika Seki Kioshima Cotica   +4 more
openaire   +4 more sources

Tinea pedis: diagnosis and management

open access: yes, 2004
Tinea pedis is one of the most commonly encountered foot infections. The fact that in most cases it is easily treatable yet still prevalent in the general population suggests it is often undiagnosed or remains untreated by health care professionals and ...
Bristow, I.R.
core  

Efinaconazole in the treatment of onychomycosis

open access: yesInfection and Drug Resistance, 2015
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. It inhibits fungal lanosterol 14α-demethylase in the ergosterol biosynthesis pathway, has potent antifungal activity against dermatophytes, as well as activity against Candida spp.
Shari R. Lipner, Richard K. Scher
openaire   +4 more sources

Which oral antifungal is best for toenail onychomycosis? [PDF]

open access: yes, 2007
Terbinafine, 250 mg taken daily for 12 weeks, is the best regimen for toenail onychomycosis due to better clinical and mycologic cure rates, tolerability, and cost effectiveness (strength of recommendation [SOR]: A, meta-analyses)
Hinojosa, Jose R., Hitchcock, Kristin
core  

Production of Fusaric Acid by Fusarium spp. in Pure Culture and in Solid Medium Co-Cultures. [PDF]

open access: yes, 2016
The ability of fungi isolated from nails of patients suffering from onychomycosis to induce de novo production of bioactive compounds in co-culture was examined.
Bertrand, S.   +7 more
core   +3 more sources

Prevalence, Risk Factors, and Spectrum of Fungi in Patients with Onychomycosis in Addis Ababa, Ethiopia: A Prospective Study

open access: yesJournal of Tropical Medicine, 2019
Background. Onychomycosis is a common refractory infection deleteriously affecting quality of life via social stigma and upsetting day-to-day activities. Objective.
Adane Bitew, Sinknesh Wolde
doaj   +1 more source

Home - About - Disclaimer - Privacy